Dr Drury has over 20 years’ experience in translational research and clinical implementation across biotech, the NHS and academia. She has a focus on the transition of new genomic technologies to clinical care, including paediatric rare disease and personalised medicine. She has experience in variant interpretation for rare disease, including for the UK 100,000 Genomes Project and has been Head of Laboratory, establishing a rapid exome sequencing service and conducting research in the field of prenatal and non-invasive prenatal diagnosis. At Geneyx she is responsible for supporting the adoption of the Geneyx Analysis platform to a broad range of users.